Product Information

SUCRALFATE 1 GM TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1651 per EA under NDC 62135043690. Its NADAC has been published 205 times since Dec 21, 2022.

FDA first approved this application on Jun 8, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUCRALFATE 1 GM TABLET

Sucralfate
$0.1651per EA

Strength

1 g/1

Manufacturer

Chartwell RX LLC

NDC

62135043690

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SUCRALFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA074415

FDA Approved

6/8/1998

TE Code

AB

On Market Since

2/17/2020

Pharmacological Classes

Aluminum Complex
Organometallic Compounds

Price Statistics

The NADAC for SUCRALFATE 1 GM TABLET has been published 205 times since Dec 21, 2022, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1651 per EA
All-time high$0.2241 (Feb 14, 2024)
All-time low$0.1563 (Nov 20, 2024)
52-week high$0.1905
52-week low$0.1651
Median price$0.1871
Average price$0.1912
Largest weekly change-11.6% (Nov 20, 2024)
Weeks tracked205
Tracking sinceDec 21, 2022

Price History

1W

-2.5%

1M

-4.4%

3M

-4.3%

6M

-13.2%

1Y

-11.7%

3Y

-21.7%

5Y

N/A

All

-21.1%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SUCRALFATE 1 GM TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM TABLET, manufactured by Chartwell RX LLC, is $0.1651 per EA (NDC 62135043690), effective Nov 18, 2026.

How has the price of SUCRALFATE 1 GM TABLET changed over time?

Over the history we have for it, the NADAC for SUCRALFATE 1 GM TABLET has declined 21.1%. It has been tracked across 205 weekly CMS publications since Dec 21, 2022.

What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM TABLET?

Since Dec 21, 2022, the NADAC for SUCRALFATE 1 GM TABLET has ranged from a low of $0.1563 (Nov 20, 2024) to a high of $0.2241 (Feb 14, 2024), with a median of $0.1871 per EA.

Are there cheaper alternatives to SUCRALFATE 1 GM TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUCRALFATE 1 GM TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures SUCRALFATE 1 GM TABLET?

SUCRALFATE 1 GM TABLET (NDC 62135043690) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.